Technavio’s latest offering, Pharmaceutical Contract Research and Manufacturing (CRAM) Market report provides a detailed analysis on the competitive scenario, the pre- and post-COVID-19 impact on businesses, and the market growth across various regions.
The pharmaceutical contract research and manufacturing (CRAM) market size is set to increase by USD 96.18 billionbetween 2021 and 2025. However, the growth momentum is anticipated to decelerate at a CAGR of over 10% over the forecast period.
Factors such as the availability of cost-efficient resources in emerging markets and the growing need to focus on core competencies will drive the growth of the pharmaceutical contract research and manufacturing (CRAM) market during 2021-2025. However, the stereotypical nature of CMOs might hamper market growth.
The strong funding on research activities will have a positive impact on the growth of vendors. On the other hand, the market concentration of CROs is expected to reduce the growth potential in the market.
The pharmaceutical contract research and manufacturing (CRAM) market report includes information on the product launches, sustainability, and prospects of leading vendors including Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Catalent Inc., Dr. Reddys Laboratories Ltd., Icon Plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, Lonza Group Ltd., and Thermo Fisher Scientific Inc.
The competitive scenario provided in the pharmaceutical contract research and manufacturing (CRAM) market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.
- By Service, the market is classified into CMO and CRO. The market is expected to witness maximum growth in the CMO segment over the forecast period.
- By Geography, the market is analyzed across North America, Asia, Europe, and ROW. Asia will have the largest share of the market.
Global Active Pharmaceutical Ingredients Market – Global active pharmaceutical ingredients market is segmented by Type (Captive APIs and Contract APIs) and Geography (APAC, North America, Europe, and ROW).
Download Exclusive Free Sample Report
Global Medical Information Market – Global medical information market is segmented by service (contract outsourcing and in-house) and geography (North America, APAC, Europe, South America, and MEA).
Download Exclusive Free Sample Report
|Pharmaceutical Contract Research And Manufacturing (CRAM) Market Scope|
|Growth momentum & CAGR||Decelerate at a CAGR of over 10%|
|Market growth 2021-2025||$ 96.18 billion|
|YoY growth (%)||12.22|
|Regional analysis||North America, Asia, Europe, and ROW|
|Performing market contribution||Asia at 35%|
|Key consumer countries||US, India, China, Germany, UK, and France|
|Competitive landscape||Leading companies, competitive strategies, consumer engagement scope|
|Companies profiled||Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Catalent Inc., Dr. Reddys Laboratories Ltd., Icon Plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, Lonza Group Ltd., and Thermo Fisher Scientific Inc.|
|Market Dynamics||Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, and market condition analysis for the forecast period.|
|Customization purview||If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.|
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.